Deepening the Partnership: Dawn Health Introduces Ekiva for Enhanced Disease Management of Paroxysmal Nocturnal Hemoglobinuria (PNH)

Contributed by: PR Newswire

Tags

Dawn-Health-Ekiva-PNH

More Like This

PR Newswire associated0

Dawn Health Secures €11.5 Million to Scale Platform & Product Suite for Next-Gen Pharma Digital Health Solutions

PR Newswire associated0

Dawn Health and Novartis Launch Cora BC for Breast Cancer Support

PR Newswire associated0

Dawn Health and Merck Launch Next-Generation Digital Ecosystem for Growth Disorders

Dawn Health and Merck are collaborating to support Growth Disorders care

Kindeva Drug Delivery and Emervax Partner To Bring Game Changing Vaccine Administration to Patients

Business Wire logo

AstraZeneca launches Evinova, a health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes

NHS England Rolls Out Evkeeza® ▼(evinacumab) for Eligible Adults and Adolescents Aged 12 Years and Older with Homozygous Familial Hypercholesterolaemia (HoFH)

Aspaveli® (pegcetacoplan) approved in Europe for use among treatment naïve adult patients with PNH